关键信息
-
基因名
TRABD
- 应用
-
别名
TRABD; TTG2; PP2447; TraB domain-containing Protein; Protein TTG2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9H4I3
-
表达区间
1-376 aa
-
氨基酸序列
MDGEEQQPPH EANVEPVVPS EASEPVPRVL SGDPQNLSDV DAFNLLLEMK LKRRRQRPNL PRTVTQLVAE DGSRVYVVGT AHFSDDSKRD VVKTIREVQP DVVVVELCQY RVSMLKMDES TLLREAQELS LEKLQQAVRQ NGLMSGLMQM LLLKVSAHIT EQLGMAPGGE FREAFKEASK VPFCKFHLGD RPIPVTFKRA IAALSFWQKV RLAWGLCFLS DPISKDDVER CKQKDLLEQM MAEMIGEFPD LHRTIVSERD VYLTYMLRQA ARRLELPRAS DAEPRKCVPS VVVGVVGMGH VPGIEKNWST DLNIQEIMTV PPPSVSGRVS RLAVKAAFFG LLGYSLYWMG RRTASLVLSL PAAQYCLQRV TEARHK
-
分子量
42.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
TRABD (TGF-β Receptor-Associated Protein with a Binds Domain) is a protein implicated in various cellular processes, including the regulation of immune responses and cellular signaling pathways. Recent studies have highlighted its crucial role in the modulation of TGF-β signaling, which is significant in cancer progression, fibrosis, and immune system disorders. Given that TGF-β signaling frequently becomes dysregulated in many diseases, understanding the function and mechanisms of TRABD can provide novel insights into potential therapeutic targets. Researchers have begun to explore the structural characteristics of TRABD through recombinant protein expression, allowing for detailed functional assays and interaction studies. Moreover, the generation of TRABD recombinant proteins is pivotal for elucidating its binding partners, post-translational modifications, and effects on downstream signaling pathways. The ongoing investigation into TRABD's role in health and disease is likely to reveal new avenues for targeted interventions in conditions where TGF-β signaling plays a detrimental role. Consequently, TRABD has emerged as a significant focus in molecular biology and therapeutic development, highlighting the importance of recombinant protein studies in advancing our understanding of complex biological systems.
